I obtained my PhD from Imperial in 2003, supervised by Professor Gad Frankel based in the Centre for Molecular Microbiology and Infection. My research was focused on the identification of proteins involved in the pathogenesis of enteropathogenic E. coli. Prior to this I had worked as a Research Assistant at Microscience Ltd (now Emergent Biosolutions), identifying and studying potential Group B Streptococcus vaccine candidates.
Following my PhD I took up a postdoctoral research position at the University of California, San Francisco analysing the pathogenesis of Pseudomonas aeruginosa, a ubiquitous bacteria involved in cystic fibrosis and nosocomial wound infections.
In 2006 I obtained a position at a biopharmaceutical company, Apollo Life Sciences, based in Sydney, Australia where I worked within the Cell Biology group on cytokines, designing bioassays and analysing signalling pathways. In 2007 I returned to the UK and worked at Thomson Scientific as an editor in the drug information pharmaceutical repository. In October 2007 I joined the Faculty of Natural Sciences as Faculty Strategic Research and Development Manager where I supported development and implementation of the Faculty research strategy. I joined the Corporate Partnerships team in November 2012 where I help to generate collaborative research opportunities with industry partners.
My role at Imperial College
-Generating collaborative research, education and translation opportunities with corporate partners;
-Promoting Faculty research including through our Corporate Partnerships booklet and website;
-Advising on trends in support of the Faculty industrial partnership strategy;
-Encouraging applications for internal and external knowledge transfer schemes
Please contact me if:
-You are interested in working with corporate partners
-You are interested in applying for knowledge transfer funding
et al., 2005, Expression of a Toxoneuron nigriceps polydnavirus-encoded protein causes apoptosis-like programmed cell death in lepidopteran insect cells, Journal of General Virology, Vol:86, ISSN:0022-1317, Pages:963-971
et al., 2005, Structural and functional studies of the enteropathogenic Escherichia coli type III needle complex protein EscJ, Molecular Microbiology, Vol:55, ISSN:0950-382X, Pages:1658-1670
et al., 2004, Identification of a novel Citrobacter rodentium type III secreted protein, EspI, and roles of this and other secreted proteins in infection, Infection and Immunity, Vol:72, ISSN:0019-9567, Pages:2288-2302
et al., 2004, Letter to the Editor: H-1, C-13, and N-15 resonance assignments of the EscJ protein, a structural component of the Type III secretion system of enteropathogenic E-coli (EPEC), Journal of Biomolecular Nmr, Vol:30, ISSN:0925-2738, Pages:387-388
et al., 2003, Novel protein vaccine candidates against Group B streptococcal infection identified using alkaline phosphatase fusions, Fems Microbiology Letters, Vol:222, ISSN:0378-1097, Pages:263-271